Treatment of obsessive compulsive disorder: psychotherapies, drugs, and other somatic treatment
- PMID: 2116405
Treatment of obsessive compulsive disorder: psychotherapies, drugs, and other somatic treatment
Abstract
Ninety percent of obsessive compulsive patients can be helped by treatment with behavior therapy and drug treatment, used sequentially or concurrently. The effectiveness of these treatments has been demonstrated in controlled clinical trials and is superior to electroconvulsive therapy and dynamic or cognitive psychotherapies for this disorder. Potent serotonin uptake inhibiting drugs, from the class of heterocyclic antidepressants, are the most effective antiobsessional medications currently available. Although these drugs usually do not induce complete remission, they can reduce obsessive compulsive symptoms by 30% to 42%. Behavior therapy combines exposure and response prevention, which the patient first learns with the therapist and then practices independently. With behavior therapy, patients confront the triggers for their anxiety and then delay, diminish, or discontinue their rituals. Reduction in symptoms with behavior therapy averages 50% or greater. Behavior therapy is usually not effective in patients who are substantially depressed, are delusional, fail to comply, or undermine therapy with covert rituals or avoidance techniques. The rare patient with very severe obsessive compulsive disorder who does not respond to behavior or drug therapy may be a candidate for psychosurgery. Modern psychosurgical procedures are quite safe and can improve symptoms in the majority of otherwise unresponsive patients.
Similar articles
-
An integrated approach to treatment of obsessive compulsive disorder.J Clin Psychiatry. 1992 Apr;53 Suppl:38-41. J Clin Psychiatry. 1992. PMID: 1532963 Review.
-
Obsessive-compulsive disorder: a treatment review.J Clin Psychiatry. 1988 Feb;49(2):48-55. J Clin Psychiatry. 1988. PMID: 2892831 Review.
-
[Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine].Encephale. 1990 Jul-Aug;16 Spec No:359-62. Encephale. 1990. PMID: 2120029 French.
-
Obsessive-compulsive disorder.Am Fam Physician. 1989 May;39(5):175-82. Am Fam Physician. 1989. PMID: 2497627
-
D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.Int Clin Psychopharmacol. 2007 Jul;22(4):230-7. doi: 10.1097/YIC.0b013e32819f8480. Int Clin Psychopharmacol. 2007. PMID: 17519647 Clinical Trial.
Cited by
-
The relationship between restrictive and repetitive behaviors in individuals with autism and obsessive compulsive symptoms in parents.Child Psychiatry Hum Dev. 2005 Winter;36(2):155-65. doi: 10.1007/s10578-005-2973-7. Child Psychiatry Hum Dev. 2005. PMID: 16228144
-
Obsessive-compulsive disorder. Diagnosis and management.Can Fam Physician. 1996 Jun;42:1169-72, 1175-8. Can Fam Physician. 1996. PMID: 8704492 Free PMC article. Review.
-
Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.Drugs. 1992 Oct;44(4):604-24. doi: 10.2165/00003495-199244040-00007. Drugs. 1992. PMID: 1281075 Review.
-
Prevalence and clinical characteristics of mental rituals in a longitudinal clinical sample of obsessive-compulsive disorder.Depress Anxiety. 2011 Oct 3;28(10):892-8. doi: 10.1002/da.20869. Epub 2011 Aug 4. Depress Anxiety. 2011. PMID: 21818825 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical